SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?


To: Steve Fancy who wrote (5431)9/28/1998 5:19:00 PM
From: Steve Fancy  Read Replies (2) | Respond to of 6136
 
Sure having trouble at this 35-36 level. A close above that could be another breakout...next significant resistance should be 40 with a forest to chop through.

Anyone heard anything new on Remune?

Agouron was mentioned several times on CNBC today. Waldholz suggested that Agouron claims superior results to two other drugs in development. I haven't seen this, but if true, maybe they're learning how to play the game.

sf